SFTRAK-M TABLETS
About SFTRAK-M TABLETS
SFTRAK-M TABLETS is a pharmaceutical product manufactured and marketed by A3A Pharmaceutical Pvt Ltd, a WHO-GMP compliant company based in Patna, Bihar, India. It contains MIRABEGRON EXTENDED RELEASE TABLETS 25 mg, and forms part of our Surgeon, Physician range.
Therapeutic segment: Surgeon, Physician.
Product information
- Composition
- MIRABEGRON EXTENDED RELEASE TABLETS 25 mg
Frequently asked questions
What is SFTRAK-M TABLETS?
SFTRAK-M TABLETS is a pharmaceutical product containing MIRABEGRON EXTENDED RELEASE TABLETS 25 mg, manufactured and marketed by A3A Pharmaceutical Pvt Ltd, Patna, Bihar, India.
What is the composition of SFTRAK-M TABLETS?
SFTRAK-M TABLETS contains MIRABEGRON EXTENDED RELEASE TABLETS 25 mg.
Which therapeutic segment does SFTRAK-M TABLETS belong to?
SFTRAK-M TABLETS is part of the Surgeon, Physician range of A3A Pharmaceutical Pvt Ltd.
Who manufactures SFTRAK-M TABLETS?
SFTRAK-M TABLETS is manufactured and marketed by A3A Pharmaceutical Pvt Ltd, a WHO-GMP compliant pharmaceutical company based in Patna, Bihar, India. For distribution, PCD franchise or bulk supply enquiries call +91-83404-30743.
Enquiry
For distribution, PCD franchise or bulk supply enquiries about SFTRAK-M TABLETS, contact A3A Pharmaceutical Pvt Ltd on +91-83404-30743 or email a3apharma@gmail.com.